Daily Stock Pick — 2025-12-13

AARD – Aardvark Therapeutics

News: "Aardvark Therapeutics receives positive trial updates and analyst coverage, leading to a rise in stock price. | Aardvark's hunger-suppressing drug candidates have significant market potential, with promising clinical programs. | Impact: +40"

Initial base score (BrainScore + News Impact): 131.039779

ADVICE DECISION: N/A

Certainty: 56%

Forecast image URL: https://stockscan.io/stocks/AARD/forecast

What reduced the score: Very low BrainScore vs. thresholds; RSI_14 extremely overbought (87.4092); elevated 30D volatility (1.183); stretched 52w position (0.7299)

Verifier note: Confirmed BrainScore baseline; while momentum (pos_30d=0.9457, Momentum_63D/126D>0) and positive news help, overbought/volatility suggest near-term risk—no adjustment to BASE warranted.